Journals / Turkish Journal of Medical Sciences / 2013 / Cilt: 43 - Sayı: 6

Human papillomavirus prevalence and type in liquid-based cervical samples from Turkish women in a selected risk group

Pages
963–970
Publication Date
2013-06-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The high-risk types of HPV detected were 16, 18, 31, 56, 53, 45, 62, 58, 59, 67, 51, 35, 73, 52, 33, 39, 68, and 82.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:To detect the prevalence and type distribution of human papillomavirus (HPV) in different cytological diagnostic categories.
📊
Key Findings & Data:Materials and methods: Between 2007 and 2010, a total of 1014 liquid-based thin preparations of cervical smears were selected and classified according to cytology results.
💡
Conclusion & Impact:The high-risk types of HPV detected were 16, 18, 31, 56, 53, 45, 62, 58, 59, 67, 51, 35, 73, 52, 33, 39, 68, and 82.
🔬Design:Research Article
📍Scope:2007 Verileri
⚙️Variables:Key words: Cytology · human papillomavirus DNA · genotype

Abstract

To detect the prevalence and type distribution of human papillomavirus (HPV) in different cytological diagnostic categories. Materials and methods: Between 2007 and 2010, a total of 1014 liquid-based thin preparations of cervical smears were selected and classified according to cytology results. HPV DNA polymerase chain reaction (PCR) was also performed using these samples. HPV DNA-positive samples were genotyped by DNA sequencing. Results: Of those enrolled in the study, 45.3% were negative cytologically, 36.4% had atypical squamous cells of undetermined significance, 0.3% had atypical squamous cells preventing the exclusion of a high-grade squamous intraepithelial lesion, 16.8% showed a low-grade squamous intraepithelial lesion, and 1.3% had an high-grade squamous intraepithelial lesion. Conclusion: PCR assays showed HPV positivity in 63.0% of cytologically negative and 90.8% of cytologically positive samples. The most common types of HPV detected were 16, 6, 18, 31, 66, 56, 53, 81, 45, and 62. Of HPV DNA-positive samples, 47.7% were high, 4.7% were intermediate, and 17.9% were low risk. The high-risk types of HPV detected were 16, 18, 31, 56, 53, 45, 62, 58, 59, 67, 51, 35, 73, 52, 33, 39, 68, and 82.

Özet

To detect the prevalence and type distribution of human papillomavirus (HPV) in different cytological diagnostic categories. Materials and methods: Between 2007 and 2010, a total of 1014 liquid-based thin preparations of cervical smears were selected and classified according to cytology results. HPV DNA polymerase chain reaction (PCR) was also performed using these samples. HPV DNA-positive samples were genotyped by DNA sequencing. Results: Of those enrolled in the study, 45.3% were negative cytologically, 36.4% had atypical squamous cells of undetermined significance, 0.3% had atypical squamous cells preventing the exclusion of a high-grade squamous intraepithelial lesion, 16.8% showed a low-grade squamous intraepithelial lesion, and 1.3% had an high-grade squamous intraepithelial lesion. Conclusion: PCR assays showed HPV positivity in 63.0% of cytologically negative and 90.8% of cytologically positive samples. The most common types of HPV detected were 16, 6, 18, 31, 66, 56, 53, 81, 45, and 62. Of HPV DNA-positive samples, 47.7% were high, 4.7% were intermediate, and 17.9% were low risk. The high-risk types of HPV detected were 16, 18, 31, 56, 53, 45, 62, 58, 59, 67, 51, 35, 73, 52, 33, 39, 68, and 82.

🔖

Cite This Article

AKYAR, I., AYDIN, Ö., YAKICIER, M. C., KOCAGÖZ, Z. T., İNCE, Ü., ÜNSAL, İ. (2013). Human papillomavirus prevalence and type in liquid-based cervical samples from Turkish women in a selected risk group. Turkish Journal of Medical Sciences, Cilt: 43 - Sayı: 6, 963–970. https://ajindex.com/articles/394128

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Kiki I, Gündoğdu M, Polat F, Gündoğdu C. Detection of human papillomavirus infection in esophageal carcinomas by the histopathological method and polymerase chain reaction technique. Turk J Med Sci 2002; 32: 223–230.
  2. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12–19. World Health Organization. Bulletin of the World Health Organization (BLT) 84: 145–150. 2006. Available at http://www. who.int/bulletin/volumes/84/2. Burkhart CG, Burkhart CN. If papillomavirus found universally in epidermal tissues, what does that mean if a PCR pap test is positive? Open Dermatol J 2009; 3: 52–53. Turkish Cervical Cancer and Cervical Cytology Research Group. Prevalence of cervical cytological abnormalities in Turkey. Int J Gynaecol Obstet 2009; 106: 206–209.
  3. Castle PE, Gravitt PE, Solomon D, Wheeler CM, Schiffman M. Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the atypical squamous cell of undetermined significance and low-grade squamous intraepithelial lesion triage study. J Clin Microbiol 2008; 46: 109–117.
  4. Cuzick J, Szarewski A, Cubie H, Hulman G, Kitchener H, Luesley D, McGoogan E, Menon U, Terry G, Edwards R et al. Management of women who test positive for high- risk types of human papillomavirus: the HART study. Lancet 2003; 362: 1871–1876.
  5. Ferreccio C, Bratti MC, Sherman ME, Herrero R, Wacholder S, Hildesheim A, Burk RD, Hutchinson M, Alfaro M, Greenberg MD et al. A comparison of single and combined visual, cytologic; and virologic tests as screening strategies in a region at high risk of cervical cancer. Cancer Epidemol Biomarkers Prev 2003; 12: 815–823.
  6. Sherman ME, Lorincz AT, Scott DR, Wacholder S, Castle PE, Glass AG, Mielzynska-Lohnas I, Rush BB, Schiffman M. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis. J Natl Cancer Inst 2003; 95: 46–52.
  7. Cuzick J, Clavel C, Petry KU, Meijer CJ, Hoyer H, Ratnam S, Szarewski A, Birembaut P, Kulasingam S, Sasieni P et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer 2006; 119: 1095–1101.
  8. Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA. Manual of Clinical Microbiology. 1st ed. Washington DC, USA: ASM Press; 2007. Centers for Disease Control